Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34+ cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients

Stem Cells

Volumn 19, Issue 1, 2001, Pages 37-45

  Gazitt, Yair ^a,b   Liu, Qun ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center ^*  (United States)

Author keywords

CD34+; CXCR4; Mobilization; SDF I

Indexed keywords

CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYCLOPHOSPHAMIDE; CYTOKINE RECEPTOR; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1; STROMAL DERIVED FACTOR 1 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; APHERESIS; ARTICLE; CELL MOTILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE MIGRATION; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION;

EID: 0035186585     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.19-1-37     Document Type: Article

References (44)

1. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation
2. Factors affecting blood stem cell collection following high dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors
3. Transplantation potential of peripheral blood stem cells induced by G-CSF
4. Optimization of stem cell mobilization
5. Transplantation potential of hematopoietic cells released into the peripheral blood for non-Hodgkin's lymphoma
6. Factors that influence collection and engraftment of autologous peripheral blood stem cells
7. Patient characteristic associated with successful mobilization and autografting of peripheral blood progenitor cells in malignant lymphoma
8. + cell yields
9. Successful PBSC mobilization with high dose G-CSF for patients failing a first round of mobilization
10. High-dose therapy with peripheral blood progenitor cell transplantation in non-Hodgkin's lymphoma
11. + progenitor cell collection in patients with hematological malignancies
12. Peripheral blood stem cell transplant for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients
13. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cells collections in 692 patients after the administration of myeloablative therapy
14. A randomized study of peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF and sequential GM-CSF followed by G-CSF in non-Hodgkin's lymphoma patients: Co-mobilization of dendritic cells and NK-cells
15. Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF followed by G-CSF in non Hodgkin's lymphoma patients: A randomized prospective study
16. Autologous transplantation with peripheral blood mononuclear cells after administration of G-CSF
17. Granulocyte colony stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high dose chemotherapy
18. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: An analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma
19. Comparative effect of GM-CSF and G-CSF on priming of peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy
20. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
21. Phase I/II study of combined G-CSF and GM-CSF administration for the mobilization of hematopoietic progenitor cells
22. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: Effects on hematopoietic recovery after high-dose chemotherapy
23. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells
24. Flt3-Ligand synergizes with GM-CSF or G-CSF to mobilize hematopoietic stem cells into the peripheral blood in mice
25. + dendritic cell precursor
26. Thrombopoietin but not erythropoietin directly stimulate multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: Distinct interaction with the ligand of c-kit and flt3
27. Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia
28. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia
29. Mechanism of flt3 ligand expression in bone marrow failure: Translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis
30. + peripheral blood stem cells in non-Hodgkins lymphoma patients
31. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
32. SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: Differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis versus suppression of progenitor proliferation
33. + cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus
34. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
35. + cell proliferation in synergy with cytokines: Possible role in progenitor survival
36. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors
37. + cells during mobilization with G-CSF
38. + cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation
39. + cells in adhesion molecule expression
40. + progenitor cells from bone marrow peripheral blood during G-Csf-Enhanced recovery
41. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells
42. Coreceptor/chemokine receptor expression on human hematopoietic cells: Biological implications for human immunodeficiency virus type 1 infection
43. + hematopoietic stem cells
44. + cells: Role in transendothelial/stromal migration and engraftment of NOD/SCID mice